Clinical Trials Browser

Spironolactone × Clear all

NCT07431216 2026-02-24

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Phase 1/2 Not yet recruiting

Glioblastoma

NCT03068910 2025-08-05

CRM008

Phase EARLY_PHASE1 Recruiting

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04723862 2025-08-05

CBS010

Phase EARLY_PHASE1 Recruiting

Polycystic Ovary Syndrome, Hyperandrogenism

NCT05933265 2025-03-06

Study of LP-184 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Neoplasm Metastasis, Neoplasms, Triple Negative Breast Neoplasms

NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Phase NA Unknown

Obesity, Polycystic Ovary Syndrome

NCT04075149 2023-10-27

CBS009

Phase EARLY_PHASE1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01431326 2023-09-06

PTN_POPS

CNSClassical hematology

Healthcare-Associated Pneumonia, Pulmonary Arterial Hypertension, Schizophrenia, Treatment-Resistant, Adenoviridae Infections, Anxiety Disorders, Arrhythmias, Cardiac, Autistic Disorder, Bipolar Disorder, Bradycardia, Central Nervous System Infections, Endocarditis, Epilepsy, Headache, Heart Arrest, Heart Failure, Hemophilia A, Herpes Simplex, Hyperaldosteronism, Hypertension, Hypokalemia, Infections, Inflammation, Influenza, Human, Sleep Initiation and Maintenance Disorders, Meningitis, Menorrhagia, Migraine Disorders, Neutropenia, Pain, Pneumonia, Retinitis, Schizophrenia, Seizures, Spasm, Staphylococcal Infections, Urinary Tract Infections, Meningitis, Bacterial, Cytomegalovirus Retinitis, Hemangioma, Capillary, Sepsis, Renal Insufficiency, Chronic, Intraabdominal Infections

NCT06005259 2023-08-22

SPIROTOX

Phase 4 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

NCT03867682 2023-08-04

Venetoclax and Lintuzumab-Ac225 in AML Patients

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01867294 2020-01-09

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Phase 2 Completed

19 enrolled 9 charts

Advanced Malignant Neoplasm

NCT02689843 2019-11-12

AntiPCO

Phase EARLY_PHASE1 Completed

Inflammation, Polycystic Ovary Syndrome

NCT02531412 2017-01-04

SPIROCAN

Phase 2/3 Unknown

Neoplasms, Critical Illness, Acute Kidney Injury

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Phase NA Completed

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT00842140 2010-07-22

Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women

Phase NA Completed

Cardiovascular Diseases, Polycystic Ovary Syndrome

NCT00004311 2005-06-24

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome

Phase 2 Completed

Acanthosis Nigricans, Endocrine System Diseases, Polycystic Ovary Syndrome, Skin Diseases, Rare Diseases